Sign In
Buy HIMS
$27.51
+0 (+0%)
At Close: Jun 03, 2026
Hims & Hers Health: Expecting A Healthy Report
10:00am, Sunday, 21'st Jul 2024
Hims & Hers Health has fallen below $20 after initial excitement over a compounded GLP-1 drug solution wanes. The health and wellness platform offers a compounded semaglutide drug at lower prices due
Here's My Top Growth Stock to Buy Right Now
09:00am, Saturday, 20'th Jul 2024
Hims & Hers' unique, brand-driven strategy can help it establish a moat in the competitive telehealth industry. Over the long term, the company can leverage user data and artificial intelligence to ge
Is This Telehealth Stock a Buy After the Recent Pullback?
11:48am, Friday, 19'th Jul 2024
Hims & Hers Health, Inc. NYSE: HIMS is a prominent player in the telehealth sector, which is part of the larger healthcare sector. The company has garnered significant attention from investors due t
Hims & Hers: The Thesis Goes Far Beyond GLP-1
05:34pm, Thursday, 18'th Jul 2024
Hims & Hers is dedicated to telehealth and provides healthcare services remotely. It has an asset-light business model that has had extraordinary growth. The company began its growth by attacking mark
Hims & Hers Health, Inc. (HIMS) Laps the Stock Market: Here's Why
06:51pm, Tuesday, 16'th Jul 2024
In the most recent trading session, Hims & Hers Health, Inc. (HIMS) closed at $23.11, indicating a +1.18% shift from the previous trading day.
Hims & Hers to Announce Second Quarter 2024 Financial Results on August 5, 2024
04:05pm, Monday, 15'th Jul 2024
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. ("Hims & Hers") (NYSE: HIMS), the leading health and wellness platform, today announced that it will report second quarter financial results af
3 Stocks Poised to 10X in the Next 5 Years
09:45am, Monday, 15'th Jul 2024
Identifying stocks with the potential to achieve extraordinary returns can be complex and rewarding. Three companies can fundamentally hit solid market value growth over the next five years.
2 Incredibly Cheap Growth Stocks to Buy Now
07:30am, Sunday, 14'th Jul 2024
These companies are on different growth trajectories, but each has something to offer long-term investors. Hims & Hers is increasing subscribers and revenue rapidly, while profitability is expanding.
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It
10:00am, Friday, 12'th Jul 2024
Hims & Hers Health (HIMS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
3 Companies Set to Positively Surprise this Earnings Season
07:56pm, Thursday, 11'th Jul 2024
Earnings season has arrived, with Friday's big bank results shifting the period into a much higher gear. The period looks to be positive, with earnings growth expected to be strong, again underpinned
2 Top-Ranked Cheap Growth Stocks to Buy in July and Hold
12:07pm, Thursday, 11'th Jul 2024
The two stocks trading under $25 per share we dive into today boast impressive growth outlooks and their improving earnings estimates help them land Zacks Rank #1 (Strong Buys).
Hims & Hers' February gains were important in bringing it over the SPAC $10 level, says Jim Cramer
08:10pm, Wednesday, 10'th Jul 2024
'Mad Money' host Jim Cramer takes a look at Hims & Hers to assess if its a good healthcare move for your portfolio.
Don't place your hopes on Hims & Hers GLP-1 business, says Jim Cramer
08:09pm, Wednesday, 10'th Jul 2024
'Mad Money' host Jim Cramer takes a look at Hims & Hers to assess if its a good healthcare move for your portfolio.
Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
06:46pm, Wednesday, 10'th Jul 2024
CNBC's Jim Cramer gave his take on the Hims & Hers Health, a digital health and wellness platform, saying it might be worth opening a position in the stock now that it's pulled back somewhat from its
Are Medical Stocks Lagging Hims & Hers Health (HIMS) This Year?
01:31pm, Monday, 08'th Jul 2024
Here is how Hims & Hers Health, Inc. (HIMS) and Novo Nordisk (NVO) have performed compared to their sector so far this year.
